Page 67 - ARNM-1-1

Advances in Radiotherapy
& Nuclear Medicine PRaG therapy for renal pelvis carcinoma

https://doi.org/10.1186/s12885-018-4212-1 Oncol, 5: 1276–1282.
14. Leighl NB, Redman MW, Rizvi N, et al., 2021, Phase II study https://doi.org/10.1001/jamaoncol.2019.1478
of durvalumab plus tremelimumab as therapy for patients 18. Kelley RK, Mitchell E, Behr S, et al., 2018, Phase II trial
with previously treated anti-PD-1/PD-L1 resistant stage IV of pembrolizumab (PEM) plus granulocyte macrophage
squamous cell lung cancer (Lung-MAP substudy S1400F, colony stimulating factor (GM-CSF) in advanced biliary
NCT03373760). J Immunother Cancer, 9: e002973.
cancers (ABC). J Clin Oncol, 36: 386.
https://doi.org/10.1136/jitc-2021-002973
https://doi.org/10.1200/jco.2018.36.4_suppl.386
15. Asna N, Livoff A, Batash R, et al., 2018, Radiation therapy
and immunotherapy-a potential combination in cancer 19. Zhao X, Kong Y, Zhang L, 2020, Anti-PD-1 immunotherapy
treatment. Curr Oncol, 25: e454–e460. combined with stereotactic body radiation therapy and
GM-CSF as salvage therapy in a PD-L1-negative patient with
https://doi.org/10.3747/co.25.4002 refractory metastatic esophageal squamous cell carcinoma:
16. Dovedi SJ, Adlard AL, Lipowska-Bhalla G, et al., 2014, A case report and literature review. Front Oncol, 10: 1625.
Acquired resistance to fractionated radiotherapy can be https://doi.org/10.3389/fonc.2020.01625
overcome by concurrent PD-L1 blockade. Cancer Res,
74: 5458–5468. 20. Smith KA, 1988, Interleukin-2: Inception, impact, and
implications. Science, 240: 1169–1176.
https://doi.org/10.1158/0008-5472.can-14-1258
https://doi.org/10.1126/science.3131876
17. Theelen WS, Peulen HM, Lalezari F, et al., 2019, Effect
of pembrolizumab after stereotactic body radiotherapy 21. Rochman Y, Spolski R, Leonard WJ, 2009, New insights into
vs pembrolizumab alone on tumor response in patients the regulation of T cells by gamma(c) family cytokines. Nat
with advanced non-small cell lung cancer: Results of the Rev Immunol, 9: 480I490.
PEMBRO-RT phase 2 randomized clinical trial. JAMA https://doi.org/10.1038/nri2580

Volume 1 Issue 1 (2023) 7 https://doi.org/10.36922/arnm.0441